Skip to main content

Quest Patient Service Centers will be closed on Thursday, November 26th and will close at 12:00 PM on Friday, November 27th in observance of Thanksgiving and to give our frontline team time to recharge. Don’t let the holiday interrupt your care. Plan your visit today.

Hide

Case Report: Complete Response of Recurrent Locally Advanced Basal Cell Carcinoma Following Addition of Vismodegib to Neoadjuvant Cemiplimab Therapy

Case Report: Complete Response of Recurrent Locally Advanced Basal Cell Carcinoma Following Addition of Vismodegib to Neoadjuvant Cemiplimab Therapy

Authors: Lambert-Swainston C, Samlowski W, Reynolds B, Hedayat A

Citation: Front Oncol. 2025 Jan 30;15:1500785. doi:10.3389/fonc.2025.1500785

Specialties: Oncology, Immunology